EdgarLookup
SC 13D/A

AMENDMENT NO. 5 TO SCHEDULE 13D

Company
Carisma Therapeutics Inc.
Filed
April 7, 2017
Accession Number
0001193125-17-115091
View Document ↗ View on SEC.gov ↗